Myopericarditis associated with varicella zoster virus infection
Related Experiment Video
Updated: Jun 16, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Kai-Liang Kao1, Shu-Jen Yeh, Chia-Chun Chen
1Department of Pediatrics, Far Eastern Memorial Hospital, Pan-Chiao, Taipei County 220, Taiwan, ROC.
Abstract:
Acute myopericarditis is a major cause of acquired heart disease worldwide in pediatric patients. Various viruses have been reported as the etiology, of which varicella zoster virus was first reported in 1953. However, since nationwide administration of the varicella vaccine, reports of varicella-associated myopericaridits have become sporadic. We report a case of varicella myopericarditis with an initial manifestation of chest pain, tachycardia, and hypotension. Typical skin vesicles developed 2 days after these symptoms, which confirmed the diagnosis. Intravenous immunoglobulin was administered before the appearance of the skin vesicles under the impression of suspected Coxsackie virus infection. Intravenous acyclovir effectively controlled the progression of the disease, and both clinical symptoms and electrocardiographic changes subsided soon after the use of an antiviral agent. Varicella zoster virus serum IgM antibody also showed positive test results. On the following visit, the patient's myocardial function had fully recovered from this episode.
Insights
Varicella zoster virus can cause acute myopericarditis in children, presenting with chest pain and shock. Prompt antiviral treatment with acyclovir led to full recovery of heart function.
Area of Science:
- Pediatrics
- Infectious Diseases
- Cardiology
Background:
- Acute myopericarditis is a significant cause of acquired heart disease in children globally.
- Varicella zoster virus (VZV) is a known, though infrequent, cause of myopericarditis.
- Widespread varicella vaccination has led to a decline in VZV-associated cases.
Observation:
- A pediatric patient presented with chest pain, tachycardia, and hypotension, indicative of acute myopericarditis.
- Characteristic skin vesicles appeared two days after initial symptoms, confirming VZV infection.
- Diagnosis was supported by positive VZV serum IgM antibody tests.
Findings:
- Intravenous acyclovir effectively managed the VZV-induced myopericarditis.
- Clinical symptoms and electrocardiographic abnormalities resolved following antiviral therapy.
- The patient experienced complete recovery of myocardial function.
Implications:
- This case highlights the importance of considering VZV as a cause of pediatric myopericarditis, even in vaccinated populations.
- Early diagnosis and prompt antiviral treatment are crucial for favorable outcomes.
- Highlighting the efficacy of acyclovir in managing VZV-related cardiac complications in children.
Related Concept Videos
Chickenpox
Myocarditis III: Medical Management
Myocarditis I: Introduction
Pericarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis III: Medical Management
